Skip to main content

Table 4 Univariate analysis of factors influencing patients’ views on whether they would participate in a trial involving a research biopsy

From: Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey

Patient characteristic

Yes

Odds ratio (95 % CI)

p valuea

N (%)

(n = 78)

Age

   

  < 65 years

37 (57 %)

1.0

 

  ≥ 65 years

41 (67 %)

1.55 (0.75–3.21)

0.236

Gender

   

 Male

59 (64 %)

1.0

 

 Female

19 (56 %)

0.71 (0.32–1.58)

0.398

Tumour type

   

 Colorectal

30 (60 %)

1.0

 

 Oesophagogastric

37 (73 %)

1.76 (0.76–4.06)

0.184

Performance status (PS)

   

 0

30 (67 %)

1.0

 

 1

36 (59 %)

0.72 (0.32–1.61)

0.423

 2

7 (70 %)

1.17 (0.26-5.16)

0.839

Previously participated in a clinical trial

   

 Yes

13 (65 %)

1.0

 

 No

64 (61 %)

1.19 (0.44–3.23)

0.733

Number of previous lines of treatment

   

 0

24 (47 %)

1.0

 

 1

31 (67 %)

2.33 (1.02–5.31)

0.045

 2+

22 (79 %)

4.13 (1.43–11.9)

0.009

Type of treatment

   

 Palliative

60 (69 %)

1.0

 

 Curative

18 (46 %)

0.39 (0.18–0.84)

0.015

CTIMP

   

 No

44 (60 %)

1.0

 

 Yes

19 (53 %)

0.74 (0.33–1.65)

0.457

  1. ap values compare the proportion of patients who answered ‘yes’: e.g. 67 % for PS0 versus 59 % for PS1 and 70 % for PS2
  2. Key: CTIMP = Clinical Trial of an Investigational Medicinal Product, pre-screening = molecular pre-screening to determine potential eligibility for a specific CTIMP study